Royal Bank Of Canada Brainstorm Cell Therapeutics Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.34 - $0.74 $72 - $156	212 Added 66.88%	529 $0
Q1 2024 Nov 05, 2024	SELL	$0.28 - $0.66 $59 - $139	-212 Reduced 40.08%	317 $0
Q1 2024 May 15, 2024	SELL	$0.28 - $0.66 $63 - $149	-227 Reduced 41.73%	317 $0
Q4 2023 Feb 14, 2024	SELL	$0.15 - $0.4 $214 - $572	-1,431 Reduced 72.46%	544 $0
Q3 2023 Nov 14, 2023	SELL	$0.2 - $2.08 $100 - $1,046	-503 Reduced 20.3%	1,975 $0
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.2 $1,890 - $3,024	945 Added 61.64%	2,478 $5,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $1,064 - $1,386	-339 Reduced 18.11%	1,533 $5,000
Q2 2021 Aug 16, 2021	BUY	$3.01 - $4.01 $5,634 - $7,506	1,872 New	1,872 $7,000

10.6M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $73.7M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.